Uric acid, heart failure survival, and the impact of xanthine oxidase inhibition

Congestive Heart Failure
Arash HarzandJoshua M Hare

Abstract

Increasing evidence suggests that serum uric acid (UA), a product of xanthine oxidase (XO), may be a useful marker for metabolic, hemodynamic, and functional staging in heart failure (HF) and a valid predictor of survival in HF patients. Recent data support an expanded role for UA and the XO pathway in the pathogenesis of HF, as studies have shown that an elevation in the enzymatic activity of XO can lead to increases in oxidative stress, endothelial dysfunction, and reduced myocardial function. Numerous population studies have previously reported that elevated UA levels are an independent predictor of cardiovascular mortality, and recent evidence suggests that lowering serum levels of UA may lead to improved outcomes in HF patients. The question of whether UA is only a marker rather than a causal factor in the pathogenesis of HF remains. Regardless of whether UA levels are ready for routine clinical use, either as a prognostic factor or novel therapeutic target, further prospective studies are necessary to demonstrate that routine measurement or reduction of UA levels improves outcomes in HF patients.

References

Dec 1, 1975·British Heart Journal·C J Bulpitt
Jan 1, 1992·Journal of Molecular Evolution·X W WuC T Caskey
Sep 1, 1966·The New England Journal of Medicine·P J CannonJ H Laragh
Jan 14, 1999·European Heart Journal·F LeyvaA J Coats
May 8, 1999·The European Respiratory Journal·M M HoeperH Fabel
Jul 3, 1999·Annals of Internal Medicine·B F CulletonD Levy
Dec 2, 1999·Atherosclerosis·F J NietoR G Cutler
Oct 26, 2001·Hypertension Research : Official Journal of the Japanese Society of Hypertension·M ImazuN Kohno
Jul 10, 2002·Circulation·Colin A J FarquharsonAllan D Struthers
Sep 7, 2002·Hypertension·Susumu WatanabeRichard J Johnson
Aug 6, 2003·Hypertension·Daniel I Feig, Richard J Johnson
Dec 25, 2003·The Journal of Physiology·Cristine E Berry, Joshua M Hare
Apr 21, 2005·Kidney International·Uday M KhoslaRichard J Johnson
Jun 21, 2005·Journal of Molecular and Cellular Cardiology·Luciano C AmadoJoshua M Hare
Aug 16, 2005·The American Journal of Cardiology·Sunao KojimaUNKNOWN Japanese Acute Coronary Syndrome Study (JACSS) Investigators
Oct 11, 2005·Free Radical Biology & Medicine·Stephan BaldusThomas Münzel
Dec 17, 2005·Circulation Research·Khalid M MinhasJoshua M Hare
Mar 15, 2006·Circulation·Wayne C LevyMilton Packer
May 5, 2006·Current Hypertension Reports·Daniel I FeigRichard J Johnson
May 6, 2006·Stroke; a Journal of Cerebral Circulation·Michiel J BosMonique M B Breteler
Jun 20, 2006·International Journal of Cardiology·Ewa A JankowskaPiotr Ponikowski
Jul 26, 2006·Circulation Journal : Official Journal of the Japanese Circulation Society·Hiroshi SakaiMinoru Horie
Sep 6, 2006·Journal of Cardiac Failure·Horacio E CingolaniNéstor G Pérez
Oct 4, 2006·Circulation·Jeffrey M Zimmet, Joshua M Hare
Oct 27, 2006·European Journal of Heart Failure·Domingo A Pascual-FigalMariano Valdes
Jun 14, 2008·Journal of the American College of Cardiology·Joshua M HareUNKNOWN OPT-CHF Investigators
Feb 25, 2009·European Journal of Internal Medicine·Anna L AlimondaAngel Llácer
Jan 29, 2011·Congestive Heart Failure·Leonardo TamarizJoshua Hare
Apr 2, 2011·European Journal of Heart Failure·Luis ManzanoUNKNOWN SENIORS Investigators

❮ Previous
Next ❯

Citations

Mar 19, 2013·Folia Microbiologica·Miroslav Pohanka
Jan 25, 2013·Heart·Mehmet KanbayRichard J Johnson
Oct 22, 2014·Open Heart·Mark F McCarty, James J DiNicolantonio
Aug 20, 2014·Nature Reviews. Rheumatology·Pascal RichetteThomas Bardin
Apr 25, 2013·Current Medical Research and Opinion·E Agabiti-Rosei, G Grassi
Oct 11, 2014·British Journal of Pharmacology·P Pagliaro, C Penna
Sep 1, 2015·International Journal of Cardiology·Micaela GliozziVincenzo Mollace
Jan 8, 2014·Annals of the Rheumatic Diseases·L Grimaldi-BensoudaUNKNOWN PGRx MI Group
Jun 3, 2014·Biochimica Et Biophysica Acta·Maria Giulia BattelliLetizia Polito
Dec 18, 2015·Dose-response : a Publication of International Hormesis Society·Rick J AllemanDavid A Brown
Nov 21, 2014·PLoS Neglected Tropical Diseases·Núria GironèsManuel Fresno
Jul 15, 2017·Acta Cardiologica·Elizabeth CausséMichel Galinier
Apr 15, 2014·Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·Kenji OnoueYoshihiko Saito
Jul 1, 2020·Terapevticheskiĭ arkhiv·M S Eliseev, A M Novikova
Jul 23, 2020·Journal of Hypertension·Maria L MuiesanUNKNOWN from the Working Group on Uric Acid, Cardiovascular Risk of the Italian Society of Hypertension
Dec 31, 2020·ESC Heart Failure·Takahide FujihashiUNKNOWN CHART-2 Investigators

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.